Mylan Pharmaceuticals Inc. vs. AstraZeneca AB
Explore the PTAB proceeding IPR2016-01324 filed by Mylan Pharmaceuticals Inc. on 2016-06-29. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2016-01324
Filing Date
2016-06-29
Accorded Filing Date
2016-06-29
Institution Decision Date
โ
Last Modified Date
2017-01-30
Proceeding Type
IPR
Termination Date
2017-01-10
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Mylan Pharmaceuticals Inc.
Represented By
Brandon WhitePatent Owner / Respondent
AstraZeneca AB
Represented By
Filko PrugoPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 31066 | Gary Williams | +1 650-843-7501 |
| 37386 | Michael Lyons | +1 650-843-7507 |
| 39266 | Soyeon Laub | +1 714-830-0512 |
| 39951 | Douglas Crisman | +1 650-843-4000 |
| 40506 | Louis Beardell Jr | +1 215-963-5067 |
| 41040 | Robert Goodell | +1 202-739-5549 |
| 41796 | Andrew Gray Iv | +1 650-843-4000 |
| 42223 | Jason White | +1 312-321-4200 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 6 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 7,456,160 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,329,680 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,466,139 B2 | US Continuation / Sibling | View Official Patent → |
| ๐ฌ๐ง United Kingdom | GB 0000313 | United Kingdom Counterpart | View Official Patent → |
| ๐ฌ๐ง United Kingdom | GB 0008837 | United Kingdom Counterpart | View Official Patent → |
| ๐บ๐ธ United States | US 6,774,122 B2 | US Continuation / Sibling | View Official Patent → |
FRESENIUS KABI USA, LLC v. AstraZeneca AB
Fresenius Kabi USA,LLC v. AstraZeneca AB
Fresenius Kabi USA, LLC v. AstraZeneca AB
InnoPharma Licensing LLC et al. v. AstraZeneca AB
InnoPharma Licensing LLC et al. v. AstraZeneca AB
InnoPharma Licensing LLC et al. v. AstraZeneca AB
Mylan Pharmaceuticals Inc. et al. v. AstraZeneca AB et al.
Mylan Pharmaceuticals Inc. v. AstraZeneca AB
Mylan Pharmaceuticals Inc. v. AstraZeneca AB
AstraZeneca Pharmaceuticals LP v. Fresenius Kabi USA, LLC
AstraZeneca Pharmaceuticals LP v. Mylan Institutional LLC
ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC.
AstraZeneca Pharmaceuticals LP v. Teva Parenteral Medicines Inc.